Centuries ago, the original cannabis concentrates were made using hand-pressed hashes, with communities on the Indian subcontinent using their hands to make charas. To use modern lingo, these were solventless concentrates, not all that different from products that consumers are finding on dispensary shelves today.
“The origins of solventless go all the way back to the beginning of when hash was first discovered,” Eric Vlosky, PurePressure’s director of marketing and business development, says.
In the 1980s and ‘90s, bubble hash had a moment in traditional cannabis markets before butane extraction gained a certain prominence in the 2000s and into the 2010s. In 2014, Phil “SoilGrown” Salazar used his girlfriend’s hair straightener to squeeze a cannabis bud and noticed an enticing oil spilling out. Here we have the creation of modern rosin. The solventless extraction industry has grown steadily ever since.
In 2015, PurePressure was formed to address this new demand. Co-founders Josh Rutherford and Ben Britton worked together to engineer a better press than what was on the market at the time (mostly repurposed T-shirt presses). The original prototype worked exceedingly well, and the company was off to the races.
More specifically, the key is in the trichomes.
Solventless operators will typically find that trichomes in the 90- to 120-micron range make up the cream of their crops. The size will make it easier to capture the resin within during the pressing process. (This is why, on a related note, hemp varieties and cannabis trim tend not to work well with ice water hash washing, but do better with dry sifting.)
Cultivars (and genetics families) that tend to do well in the solventless process include: Chem strains, Papaya strains, Cake strains, Cookies and Cream, GMO, Banana OG, Do-Si-Dos, MAC, Tropicana Cookies, and many others with new winners seemingly being found daily. The bottom line: These cultivars are heavy resin-producers, often in the traditional “indica” or “hybrid” categories.
“When it's pressed well, you tend to get the most original expression that the plant has to offer because it hasn't been modified by all kinds of super high pressures and solvents taking things apart and putting it back together,” Vlosky says.
This is why top-notch plants are critical.
Select has earned its place as an industry leader by setting stringent quality standards and focusing on the relentless pursuit of progress and innovation. Known for quality and expertise, Select provides industry-leading service, product selection and accessibility to both medical and adult-use customers in 17 states across the U.S. Select’s shop-in-shop at Planet 13 is a one-of-a-kind experience that will showcase the brand’s entire portfolio of products including Select Elite, Select Elite Live, Select Classic Bites, Select Nano Gummies and Select Ratio Drops. The Las Vegas SuperStore will be among the first retailers in the state to carry Select’s newest offerings throughout 2021.
“We are excited to partner with Curaleaf to create an exceptional showcase for their popular Select brand,” said Bob Groesbeck, co-CEO of Planet 13. “Planet 13’s tourist-friendly, experiential store is the perfect place to introduce top cannabis brands to both new and existing cannabis users.”
Patrick Larkin, senior vice president of sales at Curaleaf, said, “The Select and Planet 13 partnership is an embodiment of how we are actively investing in our retail partners and elevating our retail presence with the goal of enriching the experiences of our customers. The Planet 13 Las Vegas SuperStore is well-known as an international tourist destination, and we welcome the opportunity to introduce customers from across America and the world to America’s first national cannabis brand.”
For more information on Planet 13, visit the investor website.
For more information on Select, visit www.selectbetter.com.]]>
Senate Majority Leader Michael J. McCaffrey and Democratic colleague Sen. Joshua Miller introduced Senate Bill 568 March 9, which outlined the details of possession, taxing, local participation, home grows, social equity and retail, as well as establishing a five-member Cannabis Control Commission to oversee licensing.
“The act further provides for the creation of [a] social equity assistance fund and program to be funded by licensing and renewal fees, as appropriated,” the bill states. “The act also provides for an expedited expungement procedure for prior cannabis arrest and convictions involving 1 ounce or less of cannabis.”
The bill’s 11-tier licensing system costs for cultivators would range from $100 for up to 1,000 square feet of outdoor grows, to $20,000 for indoor grows between 90,000 and 100,000 square feet. Other annual licensing fees include $5,000 for manufacturers, $5,000 for independent testing laboratories and $20,000 for retailers, according to the bill.
Additional revenue would come in the form of a 20% tax on retail sales, which breaks down to a 10% cannabis excise tax, a traditional 7% sales tax and a 3% local sales tax that would stay in the city or town where the point of sale occurred, according to the bill. Local municipalities could opt out of issuing retail licenses, if voters adopt a ballot measure that prohibits dispensaries in their communities.
“We want to provide cities and towns with the ability to opt out, but we cannot allow an overly burdensome patchwork of regulation throughout our state,” McCaffrey said in a press release. “We know from experiences in other states that less parochialism and lower fees leads to greater transparency and a more competitive market. If a community wants to opt out and forgo tax revenue that is one thing, but we also need to make sure the process is open and transparent.”
Here are some of the key headlines from this past week:Mexico's Chamber of Deputies passed a cannabis decriminalization and legalization bill March 10 with a 316-129 vote. It now moves onto the Senate, where several amendments must be formally approved. Read more
The race is on between legislative bodies in Minnesota, as state lawmakers consider lifting a medical ban on smokable flower at the same time as passing an adult-use bill. Read more
International Women’s Day kicked off this week on March 8, and Assistant Editor Andriana Ruscitto provides insight from leaders in the business. “This is the most exciting evolving, changing, industry to date, and we all have the opportunity to build it and shape it for what it is,” one cannabis founder says. Read more
The U.S. welcomes a new attorney general with the formal confirmation of Merrick Garland. We take a look at what that means for cannabis. Read more And in Kentucky, it’s still a long road to medical cannabis legalization. Read more
And elsewhere on the web, here are the stories we’ve been reading this week:WOWT: “If you legalize marijuana, you're going to kill your kids." So says Nebraska Gov. Pete Ricketts ahead of a state hearing on medical cannabis legalization. Read more Hollywood Reporter: “Seth Rogen's newly launched cannabis lifestyle brand site, Houseplant, crashed Thursday due to the overwhelming demand. The site was so inundated, Rogen said it needed to be taken down temporarily.” Read more
MassLive: SeaWood Co. opened the first adult-use dispensary in Portland, Maine. Read more
Reuters: Thai businesses are moving fast to capitalize on new hemp and CBD laws. Read more
Ganjapreneur: South Dakota is moving forward (again) on its medical cannabis legalization, hung up by a state legislature dispute. Read more
In the state Senate, the Health and Human Services Finance and Policy Committee amended and unanimously voted, 9-0, to pass Senate File 1179 earlier this month, which includes provisions to modernize a 5-year-old medical cannabis program that currently bans manufacturers from providing dried leaf and flower for qualifying patients to smoke.
As the law stands in Minnesota, only oils and tinctures containing tetrahydrocannabinol (THC) can be consumed, which are typically more expensive than smokable flower. That has left medical cannabis patients spending more money out of pocket or, perhaps, the inclination to pursue the illicit market. According to the Minnesota Department of Health, the average cost for a 30-day supply of medical cannabis was $316 in 2019.
The goal of S.F. 1179 is to make medical cannabis more affordable and more accessible to qualifying patients, Sen. Mark Koran told the MinnPost earlier this month. A Republican, Koran authored the bill.
In addition to allowing the state’s two manufacturers—LeafLine Labs and Vireo Health of Minnesota—to cultivate and distribute dried flower for smoking, other key provisions in the bill include adding opioid addiction as one of the nine qualifying health conditions, and a process for adding a delivery method for the medical program’s 11 distribution clinics in the state.
But S.F. 1179 is not a path to full legalization, as there’s a different finish line brewing in the land of 10,000 lakes.
Cannabis Business Times and Cannabis Dispensary spoke to B-Real via phone to get his thoughts on the state of the game and what should happen next:
Raj Chander: Lots of corporate multi-state operators (MSOs) are getting into the cannabis industry, but many consumers have questioned their authenticity. How do we strike a balance between supporting business while staying true to the plant?
B-Real: There’s definitely a balance, ... but some of these brands that have come in, celebrity brands and big corporate brands, they’ve yet to find that middle ground. The one thing we know about the cannabis industry is people want to know you’ve been in the industry at any point—could be advocacy, activism, or actually someone in the culture who was cultivating. ... They want to know that you’ve actually been involved in the culture and it’s not just a money grab. And unfortunately, for a lot of corporate entities coming in, it’s a money grab, and it’s perceived as that, and some of those brands sort of fall by the wayside no matter how much money they’ve thrown at promoting and hyping up said brand. I think you see a lot more corporate entities doing deals with brands with names now to get into the industry, to get into the culture.
Anyone coming in trying to create their own brand has had a harder time. ... You have to figure out how you can engage these folks and make them familiar with your brand, and make sure that your brand quality lives up to the hype. In the last couple years we’ve seen a couple brands that have so much money to spend on marketing to be one of the most sought out brands, and when you get to their dispensary or you buy one of their products, it just does not meet the mark. Plenty of places are great in their visibility, but what they put on their counters isn’t living up to anyone’s expectations.
RC: California in particular is facing a huge issue right now with the legacy market. Why has this been such an issue, and what do you think can be done to correct it?
A woman who has impacted the industry is Lilach Mazor Power, founder and managing director at Giving Tree Dispensary, the only dispensary in Arizona with majority female ownership.
Power entered the cannabis industry in 2013 when there were little to no experts in the space. She had to make several sacrifices and worked for free for years, as she knew the company had to continue growing, she said.
But one of the most important things is that she was not afraid to jump in, take risks and work hard to get to where she aspired to be. Someone who can relate to that is Michelle Hackett, president of Riverview Farms in California.
In 2016, Hackett entered the industry when her father, Mike, was one of the first farmers permitted a license to grow medical cannabis in California. Her father wanted to take the business further than cultivation and turn it into a full seed-to-sale business. So, she left her job and jumped on board to help her father build the company, she said.
“At the start of legalization and coming into this space, there was little to no structure,” Hackett said. “We really built the business from the ground up through trial and error.”
By a vote of 70-30, the U.S. Senate today confirmed Merrick Garland to be U.S. Attorney General. While, prior to his confirmation, the new Attorney General had not been outspoken about cannabis, federal prosecution of marijuana-related crimes, or the federal-state divide over the legality of cannabis, Attorney General Garland did offer the state-legal cannabis industry in the United States reason for optimism during his recent confirmation hearings.
Most notably, responding to a question from Sen. Cory Booker (D-NJ) concerning potentially reissuing the Cole Memorandum, then-Judge Garland, testified that he did not think it was a “useful use” of limited federal resources to prosecute most cannabis-related conduct:
This is a question of the prioritization of our resources and prosecutorial discretion. It does not seem to me a useful use of limited resources that we have, to be pursuing prosecutions in states that have legalized and that are regulating the use of marijuana, either medically or otherwise. I don’t think that’s a useful use.
I do think we need to be sure there are no end-runs around the state laws that criminal enterprises are doing. So that kind of enforcement should be continued. But I don’t think it’s a good use of our resources, where states have already authorized. That only confuses people, obviously, within the state.
The Cole Memorandum was prepared in 2013 by then-Deputy U.S. Attorney General James M. Cole. It offered “Guidance Regarding Marijuana Enforcement,” identified several federal “enforcement priorities,” and provided that the federal government generally would refrain from prosecuting marijuana-related offenses unless they implicated one of those enforcement priorities.
The proposed law is supported by President Andrés Manuel López Obrador and the governing Morena party.
In 2018, Mexico’s Supreme Court ruled that an absolute ban on recreational use of marijuana was unconstitutional. Thus began the formal effort to legalize cannabis, which brings us to today’s planned vote. The country’s judicial branch has exerted influence on the process, giving legislators a deadline (extended to April 2021) to pass a bill and legalize a regulated industry around the cannabis plant.
The recent delays came out of ongoing debate over that regulatory structure: How should this new industry be arranged for the most comprehensive social and economic benefit?
The full text of the bill is embedded below.
The bill would kick regulatory authority to the existing National Commission Against Addictions (rather than a new agency, as previously stipulated in earlier versions of the bill). Licensing categories would include cultivation, transformation, sale, research and export or import. As written currently, the bill would allow anyone 18 or order to pursue a permit not only to consume and possess cannabis (up to 28 grams at a time) but to work in the industry as well.
One of Canada’s licensed producers (LPs), publicly traded Canopy Growth, which has infused and sold beverages in Canada over the past year, is now bringing its beverages below the border to the U.S. It’s starting with flavored cans of sparkling water with 20 milligrams of CBD that it’s marketing under the Quatreau brand.
“The North American market potential for CBD-infused beverages is extremely promising, and with the continued growth the industry is seeing, we know it has the potential to really disrupt other traditional beverage formats, from sparkling water and soda to beer, wine and spirits,” said Tara Rozalowsky, Canopy’s vice president of beverages and edibles.
Rozalowsky said Canopy sees the opportunity to enter the U.S. CBD beverage space due to its large size, experience manufacturing hemp products, ability to scale, and understanding of industry regulations.
The bills would help establish a medical cannabis program in the state. If passed, practitioners would be able to recommend medical cannabis to patients, and the cultivation, manufacturing, distribution, delivery, transportation, testing, preparation, packaging for sale, and sale of medical cannabis in Kentucky would be legal, the news outlet reported.
According to the report, the bills have remained in the committees and did not move in either chamber this year. And Kentucky Rep. William Lawrence, a co-sponsor on H.B. 136, said the bills are likely to go into next year’s legislative season.
His support for H.B. 136 remains strong, as he stated he thinks legalizing medical cannabis will tremendously help patients who are struggling. He also said the bill could open the job market and create a new revenue stream for farmers.
But due to the COVID-19 pandemic and the economic crisis it caused, Lawrence stated that many leaders focused on getting through that, and legalizing medical cannabis was not a priority this year; however, he is hopeful that it will get through during the 2022 legislative season.]]>
Already available in the U.S. out of Los Angeles and New Jersey, this new inventory location makes a speedy and safe packaging solution accessible to an even wider geographic. Presenting an immediately available rolling stock of child-resistant packaging in its most popular format, Duallok inventory is suitable for a wide range of products enabling cannabis brands to move quickly to market.
So how does it work? The Duallok patented double-lock design is certified under the 16 Code of Federal Regulations (CFR) 1700 guidelines for child resistance, meaning companies can take products to market knowing confidently that they are also keeping kids safe and their brand compliant.
Based in these three prime locations are a large inventory of unbranded black and white packages ready to customize as needed to meet local legislation for vape carts, pre-rolls, edibles and much more.
Once a company selects its choice color and unit quantity, the packs are available for collection or dispatch in just two to three business days and fit directly into a company’s existing packaging process. No need to provide artwork or prepare labelling, these packs are ready to ship directly to you.
Duallok partners, stationed across the U.S. and Canada, can also support companies with any additional requirements for bespoke internal product fitments or further customizations. It's a streamlined process with a dedicated project manager ready to help at every stage.
The strategic agreement offers a path forward for Fire & Flower in California, Arizona and Nevada (and beyond) by getting the brand in front of U.S. consumers and providing American Acres with a digital-forward data platform. The first Fire & Flower-branded store will open in Palm Springs, Calif., in the first half of this year.
“For us, the us is this amazing opportunity because we've already honed our craft in a really competitive environment,” CEO Trevor Fencott said. Competition is the backbone of the industry, and Fencott is eager to get into that game in more open environments—rather than the limited license markets elsewhere in the U.S. With consumer engagement and data in the foreground, he said there’s an opportunity to go deep with tech and compete on the retail side of the cannabis industry.
It wasn’t too long ago, in late 2017 when Fire & Flower got started, that product selection in Canada was practically nil: “We have dry cannabis or cannabis oil. What do you want?” was how Fencott recalled the early days of Canadian dispensary relationships, even into the adult-use legalization era.
Product selection in the U.S., he says, is more varied and innovative, generally, which allows a data-forward company like Fire & Flower to hone its craft even more.
He sees data as a pillar of cannabis retail, something necessary in this vast and burgeoning industry, particularly as product innovation drives new categories and new consumer demands. Specifically, Fencott points to businesses like Warby Parker and b8ta, “digital-native” companies that are competing in innovative ways around the likes of retail behemoth Amazon.
“Cannabis laws are out of date and disproportionately cruel and punishing when compared to the rest of the legal code. We still don’t have proper regulation for texting and driving in Missouri, but staying home and smoking weed will get you locked up,” shared Mr. Carter. “I created this campaign to amplify the voices of those who have been penalized for the very same thing that venture capitalists are now prospering from with the emerging legal cannabis market. Far too often we forget that these are real people whose everyday lives and futures have been affected by this outdated legislature - people like Bryan Rone, who can no longer pursue a career in sales because of a cannabis-related conviction in 2003.”
As demonstrated by the results of the 2020 election, more and more states are moving towards legalization as voters and lawmakers recognize the potential economic and wellness benefits the plant can provide. However, while some progress has been made, cannabis continues to be stigmatized by political agendas and arbitrary borders that still demarcate who can benefit from it, whether that’s through entrepreneurship or the positive effects of its use. MONOGRAM aims to shed light on just how antiquated these regulations are by juxtaposing them with far more divisive realities, depraved vices or dangerous transgressions - from cannibalism to flamethrowing - each of which is still permitted in the eyes of local lawmakers. These murals, billboards, mobile ads and wild-postings are currently on display across Los Angeles, San Francisco, New York, Chicago, Washington D.C. and Miami, with plans to expand to additional cities before the end of March.
While MONOGRAM endeavors towards a future through which cannabis can assume its rightful place in culture, the campaign’s depictions of real people negatively affected by the War on Drugs underscore that there is still significant work to be done to repair the injustices of its past. Beyond high-impact static visuals, the campaign will also introduce video testimonials from its eight featured individuals, offering each the chance to share their firsthand experience with inequitable punishment for cannabis offenses in the U.S. This footage, which will live on the MONOGRAM website, www.MONOGRAMCOMPANY.com, as well as the brand’s Instagram (@MONOGRAMCOMPANY), Twitter (@MONOGRAMCOMPANY) and YouTube (MONOGRAM) channels, takes viewers through the subjects’ personal dealings with the criminal justice system, speaking to issues like profiling and excessive charging. Each participant contributes details of how their life has been impacted by unjust policing practices, with irreversible consequences ranging from financial penalties to incarceration.
Through each and every initiative, MONOGRAM seeks to bring dignity to cannabis culture, which cannot be accomplished without righting the wrongs of the past. Steve Allan, CEO of The Parent Company, shared the following:
“One of the founding principles of The Parent Company was to foster social equity in cannabis. The disproportionate effects of the War on Drugs have been devastating, and we believe it is our responsibility to lay the stage to begin the process of righting the many wrongs against the Black and other minority communities.
Two years ago, they rejected Democratic Gov. Tony Evers’ proposal to decriminalize adult-use cannabis and legalize medicinal cannabis. And when Evers introduced another proposal last month, to regulate and tax adult-use cannabis for the 2021-23 biennium, Rep. Mark Born and Sen. Howard Marklein, the Joint Finance Committee co-chairs, deemed it dead on arrival.
While there’s not much hope for cannabis legalization in the governor’s budget—an avenue that also has proved fatal in other states—Evers’ proposals have continued to fan the flame of debate in Wisconsin, where only cannabidiol (CBD) sale and consumption is legal. During a March 4 virtual luncheon hosted by WisPolitics, an online magazine and news service covering political and governmental news in Wisconsin, Senate Minority Leader Janet Bewley and Assembly Minority Leader Gordon Hintz were split on whether a medical cannabis measure would survive in a standalone bill.
“That could pass,” said Bewley, a Democrat who represents a rural district in the northern part of the state. “I think that nationwide this is something that all states are going to deal with. And I think we could approach it from the way that the governor did, which is to put it in the budget with all of these different aspects and ways.”
After rejecting Evers’ budget measure last month, Marklein said cannabis legalization is a significant enough policy change that it should be debated in the light of day on its own.
Last week, Bewley said medical cannabis legalization is a no-brainer. In 2019, a Marquette University Law Poll found that 83% of Wisconsin voters supported legalizing medical cannabis with a doctor’s prescription. It also found 59% supported adult-use legalization.
Each year on March 8, we honor this tradition by highlighting the women of Cannabis Conference, an impressive roster of women shattering glass ceilings, making space for themselves and other notable women in the burgeoning cannabis industry.
This listing is just a start. As we continue to announce speakers for Cannabis Conference (Aug. 24-26, 2021, at the Paris Las Vegas Hotel & Casino), there will be plenty more women innovators, leaders, entrepreneurs and trailblazers to highlight—so keep an eye on CannabisConference.com for continued updates to our speaker roster.
Editor, Hemp Grower
We’ve rounded up some of the key cannabis headlines from the week right here.
Denver may soon allow cannabis deliveries within the city, part of a broader overhaul of local regulations. The plan also includes a new batch of business licenses that would be set up specifically for social equity applicants. Read more
North Dakota, which has seen failed attempts to legalize cannabis through the ballot box, got some good news this week in the Statehouse’s passage of an adult-use bill. Read more
BDSA’s latest forecast puts the global cannabis market at the $56-billion mark in 2026. Read more We’ve been following New Jersey’s rocky road lately, and this week contributor Raj Chander looks at how the state plans to consider social equity policies in its newly legal adult-use cannabis market Read more
And elsewhere on the web, here are the stories we’ve been reading this week:NBC 12: After Virginia legislators passed an adult-use legalization measure last weekend, businesses are now preparing themselves for future licensing and sales (which are not expected to begin until 2024). Read more FOX 17: On the other side of the Virginia state line, Tennessee hasn’t been able to get any traction on cannabis reform legislation. The newly proposed Tennessee Medical Cannabis Act might change that. Read more 8 News Now: Nevada Gov. Steve Sisolak announced eight appointments to the state’s Cannabis Advisory Commission this week. Read more San Diego Union-Tribune: County supervisors are working on regulations for unincorporated areas under their jurisdiction, with plans to introduce new cannabis business permits. Read more Cannabis Wire: The Bermuda legislature came close to legalizing cannabis, but the measure was shot down by the British overseas territory’s Senate. Read more
Location: Evart, Mich.
Title: General Manager, Cultivation, Lume Cannabis Co.
One word to describe your cultivation style: Innovative
Indoor, outdoor, greenhouse or a combination: Indoor
Can you share a bit of your background and how you and your company got to the present day?
According to the proposal, the updated requirements will apply to projects regarding greenhouse building envelopes, greenhouse lighting, indoor controlled environment horticulture (CEH) lighting and indoor CEH dehumidification.
It is essential for cannabis and non-cannabis growers, LED manufacturers, engineers, distributors, energy-efficient consultants, research groups, industry trade groups, as well as facility managers, engineers and developers to be aware of the suggested changes, the proposal states.
The proposed code requirements are listed in the proposal as follows:
Horticultural Lighting Minimum Efficacy (indoor CEH lighting):For indoor CEH operations, luminaires with removable lamps will be required to use lamps with a photosynthetic photon efficacy (PPE) of at least 1.9 micromoles per joule.Luminaires without removable lamps shall meet a minimum luminaire PPE of 1.9 micromoles per joule.This will allow the use of efficient double-ended HPS lamps; most LED luminaires will qualify. The minimum efficacy requirements only apply to CEH spaces with more than 40 kW of aggregate horticultural lighting load. This equates to approximately (36) 1000W HPS luminaires.
Horticultural Lighting Minimum Efficacy (greenhouse lighting):